Califf RM, Stump D, Topol EJ, Mark DB. Economic and cost-effectiveness in evaluating the value of cardiovascular therapies. The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy. Am Heart J. 1999 May; 137(5):S90-3.